Research and Development of Biotechnological Tools for White-nose Syndrome

The summary for the Research and Development of Biotechnological Tools for White-nose Syndrome grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Fish and Wildlife Service, which is the U.S. government agency offering this grant.
Research and Development of Biotechnological Tools for White-nose Syndrome: The U.S. Fish and Wildlife Service (Service) is making funding available in 2022 and 2023 for research and development of enduring solutions to manage white-nose syndrome (WNS) in bats. The Service provides financial and technical assistance to nongovernmental, university, and private researchers, as well as state and local governments, Native American tribes, and federal agencies, for the management of WNS and conservation of bats. Projects supported under this funding opportunity will investigate, develop, evaluate, and implement innovative biotechnologies to eliminate the threat of WNS to bats in North America. Since 2007, white-nose syndrome has caused the deaths of millions of bats in North America. The disease is caused by an invasive fungus, Pseudogymnoascus destructans (Pd), in the Phylum Ascomycota, that grows best in cold, damp, dark environments like those preferred by hibernating bats. Twelve species of bats in temperate North America are known to be susceptible to infections by Pd, but the severity of WNS varies considerably among them. Several species suffer high rates of mortality from WNS while others suffer only minor infections. An additional six North American bat species are known to have been exposed to Pd but have not been shown to suffer infection. In Europe and Asia, where Pd likely originated, multiple bat species are known to be susceptible to WNS, but with only minor infections and no evidence of mass mortality from the disease. As of August 2022, WNS is confirmed or suspected in bats in 39 states and eight Canadian provinces, and evidence of the causative fungus, Pd, has been detected in at least four additional states without signs of the disease. For information on WNS and previously funded projects, please see: http://www.whitenosesyndrome.org/ Growth in our scientific understanding of WNS, Pd, and susceptible bats has been rapid since the disease was first identified in 2007. Evidence from multiple lines of investigation, along with recent advances in biotechnology, have laid the groundwork for developing biotechnological tools that may put an end to the threat this invasive species poses to bats in North America. Funding through the Research and Development of Biotechnological Tools for WNS grant opportunity will advance projects that leverage knowledge about WNS, fungal pathogens, invasive species, wildlife diseases and other relevant topics to produce enduring solutions to WNS in North America. We seek management solutions that are pathogen-specific, effective, scalable, and safe for native biota and environments. For this opportunity, we consider biotechnological tools to be those that involve the modification of an organism or genome for the purposes of acting on the function of an organism (in this case, Pd). Projects submitted to this opportunity should clearly achieve progress toward an implementable management tool. Collaborations are encouraged and applicants are invited to contact a member of the Service's WNS coordination team (below) while developing their projects. Goal: Eliminate the threat of Pd to hibernating bats in North America. Objective 1: Develop biotechnological tools that remove or suppress Pd's pathogenic properties, making it unable to cause severe disease. Objective 2: Develop biotechnological tools that reduce or eliminate the environmental reservoir of Pd in treated sites.
Federal Grant Title: Research and Development of Biotechnological Tools for White-nose Syndrome
Federal Agency Name: Fish and Wildlife Service (DOI-FWS)
Grant Categories: Recovery Act
Type of Opportunity: Discretionary
Funding Opportunity Number: F23AS00037
Type of Funding: Cooperative Agreement
CFDA Numbers: 15.684
CFDA Descriptions: Information not provided
Current Application Deadline: March 31st, 2023
Original Application Deadline: March 31st, 2023
Posted Date: October 4th, 2022
Creation Date: October 4th, 2022
Archive Date: May 6th, 2023
Total Program Funding: $1,500,000
Maximum Federal Grant Award: $300,000
Minimum Federal Grant Award: $50,000
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: October 4th, 2022
Applicants Eligible for this Grant
State governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Additional eligible applicants include nonprofits having a 501(c)4 and 501(c)5 status with the IRS. This funding opportunity is open to domestic and foreign applicants. Additional information for foreign entities is included below.  To be eligible, the following conditions must be met:  1. Applications must clearly address the stated objective of this funding program, as identified above.  2. Applicants must be in good standing on previously awarded Federal grant agreements, with no outstanding reports or obligations, and a record of successful use of funds from previous WNS grants (if applicable).  When an applicant is carrying two or more active WNS awards while applying for another, the  Service has an administrative obligation to verify that there are no correctable problems in implementing the existing awards. The Service will review the reasons why those grants are still open before proceeding with further consideration. Previous recipients that demonstrate their effective use of WNS funds will not be affected. Previous recipients that have taken no significant action on any one of their two or more preexisting awards will not be considered eligible to apply for new funds from the WNS program until the issue is resolved.
Grant Announcement Contact
Shelley DiBona
[email protected]
[email protected]
Similar Government Grants
F24AS00367 FWS - White-nose Syndrome Research for Conservation Grants - 2024
F24AS00295 White-nose Syndrome Grants to States and Tribes - 2024
F23AS00339 - White-nose Syndrome Research and Conservation Grants - 2023
F23AS00330 White-nose Syndrome Grants to States and Tribes - 2023
F22AS00291 White-nose Syndrome Research for Conservation Grants 2022
Region 5 White-Nose Syndrome Research Grants
Region 5 White-Nose Syndrome Grants to States and Tribes
White-Nose Syndrome Grants to States and Tribes.
More Grants from the Fish and Wildlife Service
F24AS00414 Fisheries Restoration and Irrigation Mitigation Act Fiscal Year 2024
F24AS00365 Wisconsin Headwaters to Coast Initiative
F25AS00377 - FY 2025 - Sportfishing and Boating Safety Act - Boating Infrastructure Grant ...
F25AS00378 - FY 2025 - Sportfishing and Boating Safety Act - Boating Infrastructure Grant ...
F25AS00014 Sea Duck Joint Venture FY25 Competitive Grants

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com